Skip to main content
. 2025 Jun 13;9:66. doi: 10.1186/s41687-025-00895-0

Table 2.

Scores of GCLQ and its subscales of women with endometrial cancer (N = 105)

Symptom clusters Total sample
(N = 105)
LLL
(n = 41)
Non-LLL
(n = 64)
Comparison
between groups
Effect size
Mean (SD) Mean (SD) Mean (SD) p a d
GCLQ _ total score 3.42 (3.53) 7.12 (2.77) 1.05 (1.05) 0.000 3.18
 Physical functioning 0.68 (1.11)) 1.51 (1.33) 0.14 (0.39) 0.000 1.55
 Numbness 1.01 (1.25) 2.12 (1.25) 0.30 (0.52) 0.000 2.07
 General swelling 0.49 (0.75) 1.05 (0.86) 0.13 (0.33) 0.000 1.55
 Limb-related swelling 0.13 (0.39) 0.29 (0.56) 0.03 (0.18) 0.001 0.69
 Infection 0.30 (0.64) 0.66 (0.82) 0.08 (0.32) 0.000 1.02
 Heaviness 0.30 (0.46) 0.68 (0.47) 0.06 (0.24) 0.000 1.78
 Aching 0.50 (0.50) 0.80 (0.40) 0.31 (0.47) 0.000 1.10

SD standard deviation, LLL lower limb lymphedema, GCLQ Gynecologic Cancer Lymphedema Questionnaire

a Independent-sample t-tests for the scores of the GCLQ and its subscales